Clinical Trials Browser

Phase 1 × Congenital Abnormalities × laromustine × Clear all

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00098436 2013-07-18

Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias

Phase 1 Completed

25 enrolled

LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies

Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias